These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21492349)

  • 1. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.
    Riedl M; Rosales A; Zimmerhackl LB; Jungraithmayr T
    Pediatr Transplant; 2011 May; 15(3):225-8. PubMed ID: 21492349
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.
    Zimmerhackl LB; Hofer J; Cortina G; Mark W; Würzner R; Jungraithmayr TC; Khursigara G; Kliche KO; Radauer W
    N Engl J Med; 2010 May; 362(18):1746-8. PubMed ID: 20445192
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab for atypical hemolytic-uremic syndrome.
    Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M
    N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328
    [No Abstract]   [Full Text] [Related]  

  • 7. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
    Köse O; Zimmerhackl LB; Jungraithmayr T; Mache C; Nürnberger J
    Semin Thromb Hemost; 2010 Sep; 36(6):669-72. PubMed ID: 20865644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series.
    Forbes TA; Bradbury MG; Goodship TH; McKiernan PJ; Milford DV
    Pediatr Transplant; 2013 May; 17(3):E93-9. PubMed ID: 23461281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
    Saland J
    Pediatr Nephrol; 2014 Mar; 29(3):329-32. PubMed ID: 24362724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.
    Remuzzi G; Ruggenenti P; Colledan M; Gridelli B; Bertani A; Bettinaglio P; Bucchioni S; Sonzogni A; Bonanomi E; Sonzogni V; Platt JL; Perico N; Noris M
    Am J Transplant; 2005 May; 5(5):1146-50. PubMed ID: 15816899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E; Alberti M; Noris M
    J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
    Taylor CM; Machin S; Wigmore SJ; Goodship TH;
    Br J Haematol; 2010 Jan; 148(1):37-47. PubMed ID: 19821824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic uremic syndrome recurrence after renal transplantation.
    Loirat C; Fremeaux-Bacchi V
    Pediatr Transplant; 2008 Sep; 12(6):619-29. PubMed ID: 18482212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
    Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report.
    Châtelet V; Lobbedez T; Frémeaux-Bacchi V; Ficheux M; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 2010 Dec; 42(10):4353-5. PubMed ID: 21168697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir.
    Olie KH; Goodship TH; Verlaak R; Florquin S; Groothoff JW; Strain L; Weening JJ; Davin JC
    Am J Kidney Dis; 2005 Jan; 45(1):e12-5. PubMed ID: 15696434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.